SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-012378
Filing Date
2018-05-09
Accepted
2018-05-09 16:02:16
Documents
65
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sndx-10q_20180331.htm 10-Q 1642099
2 EX-10.1 sndx-ex101_169.htm EX-10.1 17285
3 EX-31.1 sndx-ex311_11.htm EX-31.1 10280
4 EX-31.2 sndx-ex312_9.htm EX-31.2 10726
5 EX-32.1 sndx-ex321_10.htm EX-32.1 11875
  Complete submission text file 0001564590-18-012378.txt   5969996

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sndx-20180331.xml EX-101.INS 1355648
7 XBRL TAXONOMY EXTENSION SCHEMA sndx-20180331.xsd EX-101.SCH 43418
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sndx-20180331_cal.xml EX-101.CAL 40590
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sndx-20180331_def.xml EX-101.DEF 121082
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20180331_lab.xml EX-101.LAB 279611
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20180331_pre.xml EX-101.PRE 235908
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 18818200
SIC: 2834 Pharmaceutical Preparations